Picture of Phaxiam Therapeutics SA logo

PHXM — Phaxiam Therapeutics SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Erytech Granted U.S. FDA Fast Track Designation For Eryaspase In Hypersensitive All

July 29 (Reuters) - Erytech Pharma SA  ERYP.PA :
    * ERYTECH GRANTED U.S. FDA FAST TRACK DESIGNATION FOR
ERYASPASE IN
HYPERSENSITIVE ALL

Source text for Eikon:  ID:nGNXbmMd2T 
Further company coverage:  ERYP.PA 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Phaxiam Therapeutics SA

See all news